Faccidomo Sara, Reid Grant T, Agoglia Abigail E, Ademola Sherifat A, Hodge Clyde W
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.
Behav Brain Res. 2016 Feb 1;298(Pt B):286-90. doi: 10.1016/j.bbr.2015.11.018. Epub 2015 Nov 19.
Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) is a multifunctional enzyme that is required for synaptic plasticity and has been proposed to be a primary molecular component of the etiology of alcohol addiction. Chronic alcohol intake upregulates CaMKIIα protein expression in reward-related brain regions including the amygdala and nucleus accumbens, and CaMKIIα activity in the amygdala is required for the positive reinforcing effects of alcohol, suggesting this system promotes consumption in the early stages of alcohol addiction. Alternatively, the medial prefrontal cortex (mPFC) is known to inhibit limbic activity via CaMKII-dependent excitatory projections and may, therefore, enable top-down regulation of motivation. Here we sought to remove that regulatory control by site-specifically inhibiting CaMKII activity in the mPFC, and measured effects on the positive reinforcing effects of sweetened alcohol in C57BL/6J mice. Infusion of the CAMKII inhibitor KN-93 (0-10.0 μg) in the mPFC primarily increased alcohol+sucrose reinforced response rate in a dose- and time-dependent manner. KN-93 infusion reduced response rate in behavior-matched sucrose-only controls. Importantly, potentiation of operant responding for sweetened alcohol occurred immediately after infusion, at a time during which effects on sucrose responding were not observed, and persisted through the session. These results suggest that endogenous CaMKII activity in the mPFC exerts inhibitory control over the positive reinforcing effects of alcohol. Downregulation of CaMKII signaling in the mPFC might contribute to escalated alcohol use.
钙/钙调蛋白依赖性蛋白激酶II(CaMKII)是一种多功能酶,对于突触可塑性至关重要,并且被认为是酒精成瘾病因的主要分子成分。长期摄入酒精会上调包括杏仁核和伏隔核在内的与奖赏相关脑区中的CaMKIIα蛋白表达,并且杏仁核中的CaMKIIα活性是酒精产生正性强化作用所必需的,这表明该系统在酒精成瘾的早期阶段促进饮酒行为。另外,内侧前额叶皮质(mPFC)已知可通过依赖CaMKII的兴奋性投射来抑制边缘系统活动,因此可能实现对动机的自上而下调节。在这里,我们试图通过特异性抑制mPFC中的CaMKII活性来消除这种调节控制,并测量其对C57BL/6J小鼠中加糖酒精正性强化作用的影响。在mPFC中注入CaMKII抑制剂KN-93(0 - 10.0μg)主要以剂量和时间依赖性方式增加了酒精+蔗糖强化的反应率。在行为匹配的仅蔗糖对照组中,KN-93注入降低了反应率。重要的是,对加糖酒精的操作性反应增强在注入后立即出现,此时未观察到对蔗糖反应的影响,并且在整个实验过程中持续存在。这些结果表明,mPFC中的内源性CaMKII活性对酒精的正性强化作用发挥抑制控制。mPFC中CaMKII信号的下调可能导致酒精使用的增加。